Glyceraldehyde 3-phosphate dehydrogenase negatively regulates human immunodeficiency virus type 1 infection

20Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Host proteins are incorporated inside human immunodeficiency virus type 1 (HIV-1) virions during assembly and can either positively or negatively regulate HIV-1 infection. Although the identification efficiency of host proteins is improved by mass spectrometry, how those host proteins affect HIV-1 replication has not yet been fully clarified.Results: In this study, we show that virion-associated glyceraldehyde 3-phosphate dehydrogenase (GAPDH) does not allosterically inactivate HIV-1 reverse transcriptase (RT) but decreases the efficiency of reverse transcription reactions by decreasing the packaging efficiency of lysyl-tRNA synthetase (LysRS) and tRNALys3 into HIV-1 virions. Two-dimensional (2D) gel electrophoresis demonstrated that some isozymes of GAPDH with different isoelectric points were expressed in HIV-1-producing CEM/LAV-1 cells, and a proportion of GAPDH was selectively incorporated into the virions. Suppression of GAPDH expression by RNA interference in CEM/LAV-1 cells resulted in decreased GAPDH packaging inside the virions, and the GAPDH-packaging-defective virus maintained at least control levels of viral production but increased the infectivity. Quantitative analysis of reverse transcription products indicated that the levels of early cDNA products of the GAPDH-packaging-defective virus were higher than those of the control virus owing to the higher packaging efficiencies of LysRS and tRNALys3 into the virions rather than the GAPDH-dependent negative allosteric modulation for RT. Furthermore, immunoprecipitation assay using an anti-GAPDH antibody showed that GAPDH directly interacted with Pr55gag and p160gag-pol and the overexpression of LysRS in HIV-1-producing cells resulted in a decrease in the efficiency of GAPDH packaging in HIV particles. In contrast, the viruses produced from cells expressing a high level of GAPDH showed decreased infectivity in TZM-bl cells and reverse transcription efficiency in TZM-bl cells and peripheral blood mononuclear cells (PBMCs).Conclusions: These findings indicate that GAPDH negatively regulates HIV-1 infection and provide insights into a novel function of GAPDH in the HIV-1 life cycle and a new host defense mechanism against HIV-1 infection. © 2012 Kishimoto et al.; licensee BioMed Central Ltd.

Figures

  • Figure 1 Confirmation of GAPDH incorporation into HIV-1 virions. (A) HIV-1LAV-1 virions within the pI range of 6.85-9.30 and the molecular weigh depleted fraction and CD45-containing fraction. CD45 and CA levels were Samples from the CD45-immunoaffinity-depleted fraction (CD45-depleted identified above their respective lanes. The antibodies used are indicated o isozymes. The upper panel shows the results of western immunoblotting u corresponding SYPROW Ruby-stained gel. (D) Comparison of pI values of G panel), and CEM cells (lower panel). GAPDH isozymes were detected by we are shown in the figure.
  • Figure 2 Effects of GAPDH packaging defect inside virions on HIV-1 replication. (A) Effects of GAPDH siRNA treatment on CEM/LAV-1 cells. Viable cells (left) and dead cells (right) were assessed by trypan blue staining. (B) GAPDH siRNA knockdown efficiency is confirmed by western immunoblotting. Expression of GAPDH was analyzed in cell lysates from CEM/LAV-1 cells transfected with GAPDH or control siRNA 72 h after transfection. (C) Effects of GAPDH siRNA on incorporation of GAPDH and HIV-1 proteins inside virions. The incorporation of GAPDH, gp120, RT, Pr55gag, or CA was analyzed by western immunoblotting of lysates from viruses produced from CEM/LAV-1 cells transfected with GAPDH or control siRNA. The anti-GAPDH antibody and HIV-1-positive plasma were used for western immunoblotting. (D) Effects of GAPDH siRNA on virus release in CEM/LAV-1 cells transfected with GAPDH or control siRNA. The virus release in culture supernatant was directly determined by p24 ELISA. The mean values of at least three independent experiments are shown. (E) Effects of GAPDH siRNA on the incorporation of HIV genomic RNA into viral particles. The level of genomic RNA in the control virus (normalized to RT activities) was set as 100%. (F) Infectivity of GAPDHpackaging-defective virus. Infectivity was evaluated on the basis of the luciferase activity in lysates of TZM-bl cells. The value in the control experiment was set as 100%. The mean values of at least three independent experiments are shown. (G) Effect of defect in GAPDH packaging on reverse transcription in TZM-bl cells. The early strong-stop DNA products were determined by quantitative real-time PCR analysis as described in “Methods”. The significance of difference (Student’s t-test) is indicated as follows: *, p<0.01; n.s., not significant. The mean values of at least three independent experiments are shown. The error bars denote the standard deviation.
  • Figure 3 Packaging of LysRS and tRNALys3 is regulated by GAPDH. (A) Effect of GAPDH on enzymatic activity of HIV-1 RT. RT activity assay was performed as described in “Methods”. The value in the control experiment was set as 100%. The activity in the presence of GAPDH (RT: GAPDH ratio= 1:10 or 1:100) is shown as the activity relative to that of the control. The mean values of at least three independent experiments are shown. Packaging of (B) LysRS and (C) tRNALys3 in GAPDH-packaging-defective virus. (B) LysRS and GAPDH were detected by western immunoblotting using anti-LysRS and anti-GAPDH antibodies in lysates from viral particles produced from CEM/LAV-1 cells transfected with GAPDH or control siRNA. (C) Incorporated tRNALys3 level was determined by reverse transcription quantitative PCR analysis as described in “Methods” and normalized by viral genomic RNA level. The amount of tRNALys3 in the control virus was set as 100%. The mean values of at least three independent experiments are shown. (D) Interaction of GAPDH with Pr55gag and p160gag-pol. GAPDH was immunoprecipitated from the clarified lysate from CEM/LAV-1 cells with the anti-GAPDH antibody. The precipitated proteins were analyzed by western immunoblotting using the indicated antibodies to the proteins shown (anti-p24 antibody for Pr55gag and anti-RT antibody for p160gag-pol), and were visualized by enhanced chemiluminescence analysis. The significance of difference (Student’s t-test) is indicated as follows: *, p<0.01; n.s., not significant. The error bars denote the standard deviation. (E) The packaging of GAPDH in the enhanced-LysRS-packaging virus. The packaging efficiencies of LysRS and GAPDH were analyzed in lysates from viral particles produced from HEK293 cells cotransfected with pNL-CH and either the LysRS expression or control vector.
  • Figure 4 Effects of enhanced GAPDH packaging inside virions on HIV packaging efficiency of GAPDH was analyzed in lysates from viral particles GAPDH expression or control vector. (B) Infectivity of enhanced-GAPDH-pa (2 ng of p24 antigen) of the enhanced-GAPDH-packaging virus or the cont mean values of at least three independent experiments are shown. (C) Qua Incorporated tRNALys3 level was determined by reverse transcription quant genomic RNA level. The amount of tRNALys3 in the control virus was set as shown. (D) Enhanced GAPDH packaging inside virions decreased reverse tr amount (20 ng of p24 antigen) of the enhanced-GAPDH-packaging virus o products) were determined as described in “Methods”. The significance of values of at least three independent experiments are shown. The error bars
  • Figure 5 Schematic illustration showing the mechanism by which GAPDH negatively regulates HIV-1 infection. A single copy of each molecule is shown for simplicity. As described in detail elsewhere [20,26,27], a Pr55gag/p160gag-pol/viral RNA complex interacts with a tRNALys3/ LysRS complex. Although the actual conformation of the Pr55gag/p160gag-pol/viral RNA complex is still unclear, findings of this study suggest that GAPDH and tRNALys3/LysRS complex may compete with each other for interaction with the binding site within Pr55gag and p160gag-pol.

References Powered by Scopus

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

220526Citations
N/AReaders
Get full text

New insights into an old protein: The functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase

730Citations
N/AReaders
Get full text

Specific incorporation of cyclophilin a into HIV-1 virions

677Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Dengue virus NS1 protein interacts with the ribosomal protein RPL18: This interaction is required for viral translation and replication in Huh-7 cells

67Citations
N/AReaders
Get full text

Measuring glutathione redox potential of HIV-1-infected macrophages

51Citations
N/AReaders
Get full text

Engineering of soybean mosaic virus as a versatile tool for studying protein-protein interactions in soybean

31Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kishimoto, N., Onitsuka, A., Kido, K., Takamune, N., Shoji, S., & Misumi, S. (2012). Glyceraldehyde 3-phosphate dehydrogenase negatively regulates human immunodeficiency virus type 1 infection. Retrovirology, 9. https://doi.org/10.1186/1742-4690-9-107

Readers over time

‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 13

52%

Researcher 9

36%

Professor / Associate Prof. 2

8%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 10

43%

Biochemistry, Genetics and Molecular Bi... 5

22%

Immunology and Microbiology 5

22%

Pharmacology, Toxicology and Pharmaceut... 3

13%

Save time finding and organizing research with Mendeley

Sign up for free
0